ARMSTRONG ADVISORY GROUP, INC

Position in ABBV — AbbVie Inc.

CIK 1932952 NEEDHAM, MA

Position in ABBV

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$2,313,326

+$298,282 QoQ

Shares Held

9,193

-0.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.06%

of 13F equity value

Holder Rank

#729

of 1,872 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ARMSTRONG ADVISORY GROUP, INC holds $13,083,941 across 15 Drug Manufacturers - General names. ABBV ranks #2 (17.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,723	$8,063,768
2	ABBV	AbbVie Inc. This page	9,193	$2,313,326
3	JNJ	Johnson & Johnson	5,400	$1,371,438
4	PFE	Pfizer Inc	10,400	$250,432
5	MRK	Merck & Co., Inc.	1,833	$235,540
6	BMY	Bristol Myers Squibb Co	4,009	$230,998
7	GILD	Gilead Sciences, Inc.	1,606	$202,902
8	AZN	Astrazeneca PLC	715	$135,578

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,313,326	9,193	-0.8%	Shares	Sole	2026-07-13
2026-03-31	$2,015,044	9,265	-1.6%	Shares	Sole	2026-04-10
2025-12-31	$2,151,233	9,415	-0.8%	Shares	Sole	2026-01-08
2025-09-30	$2,197,314	9,490	+0.1%	Shares	Sole	2025-10-08
2025-06-30	$1,759,677	9,480	-3.7%	Shares	Sole	2025-07-14
2025-03-31	$2,062,095	9,842	0.0%	Shares	Sole	2025-04-10
2024-12-31	$1,748,923	9,842	+0.6%	Shares	Sole	2025-01-14
2024-09-30	$1,932,144	9,784	-0.5%	Shares	Sole	2024-10-11
2024-06-30	$1,686,556	9,833	-3.8%	Shares	Sole	2024-07-12
2024-03-31	$1,860,879	10,219	0.0%	Shares	Sole	2024-04-12
2023-12-31	$1,583,638	10,219	-1.8%	Shares	Sole	2024-01-17
2023-09-30	$1,551,416	10,408	+1.0%	Shares	Sole	2023-10-11
2023-06-30	$1,388,123	10,303	-6.4%	Shares	Sole	2023-07-06
2023-03-31	$1,754,344	11,008	-1.9%	Shares	Sole	2023-04-07
2022-12-31	$1,814,233	11,226	—	Shares	Sole	2023-01-17
No filing history on record for this holder in this stock.